Biologic Drugs With Established Pharmaceutical Class: Hydrolytic Lysosomal Glucocerebroside-specific Enzyme
✉ Email this page to a colleague
Biologic Drugs With Established Pharmaceutical Class: Hydrolytic Lysosomal Glucocerebroside-specific Enzyme
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Genzyme Corporation | CEREZYME | imiglucerase | For Injection | 020367 | 1994-05-23 | ⤷ Subscribe | ⤷ Subscribe |
| Genzyme Corporation | CEREZYME | imiglucerase | For Injection | 020367 | 1994-05-23 | ⤷ Subscribe | ⤷ Subscribe |
| Genzyme Corporation | CEREZYME | imiglucerase | For Injection | 020367 | 1994-05-23 | ⤷ Subscribe | ⤷ Subscribe |
| Pfizer Inc. | ELELYSO | taliglucerase alfa | For Injection | 022458 | 2012-05-01 | ⤷ Subscribe | ⤷ Subscribe |
| Shire Human Genetic Therapies, Inc. | VPRIV | velaglucerase alfa | For Injection | 022575 | 2010-02-26 | ⤷ Subscribe | ⤷ Subscribe |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
